Phase I Trial of 90y-Dotatoc Therapy in Children and Young Adults With Refractory Solid Tumors That Express Somatostatin Receptors
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.110.075226
Full Text
Open PDFAbstract
Available in full text
Date
September 16, 2010
Authors
Publisher
Society of Nuclear Medicine